Correction to: Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers (Alzheimer's Research & Therapy, (2021), 13, 1, (130), 10.1186/s13195-021-00871-y)

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following the publication of the original article [1], the authors discovered that in contrast to what is stated in the article, the variable residualized leukocyte telomere length (rLTL) was not residualized for age, only gender. However, as the article describes, the effect of age and quadratic age were still accounted for by including these variables into the statistical models, as is common practice in the field. The results and conclusions reported in the paper remain the same, although potential residual confounding between rLTL tertile groups and chronological age must be considered when interpreting the findings. Future studies with narrow age-cohort designs will be needed to confirm the reported results. The original article [1] has been updated.

Cite

CITATION STYLE

APA

Hackenhaar, F. S., Josefsson, M., Adolfsson, A. N., Landfors, M., Kauppi, K., Hultdin, M., … Pudas, S. (2024, December 1). Correction to: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers (Alzheimer’s Research & Therapy, (2021), 13, 1, (130), 10.1186/s13195-021-00871-y). Alzheimer’s Research and Therapy. BioMed Central Ltd. https://doi.org/10.1186/s13195-024-01388-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free